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Introduction 
 
Introduction 
  
Dementia is a convoluted condition affecting the patient directly and also affecting 
the people around the patient such as family members and carers.1 Due to the 
continuing increasing prevalence of dementia and the progressive characteristic 
associated with it, early disease management and treatment is of utmost 
importance. Pharmacists can support both patients and carers. Training programmes 
are available to pharmacists, including Dementia Friends, Dementia Champions and 
programmes run by the Centre for Pharmacy postgraduate Education (CPPE) to help 
improve the care of dementia patients. 
  
Focal points 
 To identify current training, confidence and knowledge of dementia by 
pharmacists. 
 Although confident with dealing with dementia patients and their carers, few 
pharmacists had participated in training. 
 Dementia training needs to be further developed and encouraged for 
pharmacists. 
  
  
Aims 
This study aimed to understand the current role pharmacists play in dementia care. 
  
Objectives 
The study objectives were to identify training completed along with confidence and 
knowledge relating to dementia. 
  
Methods 
A cross sectional survey aimed at community pharmacists practising in West London 
pharmacies was conducted, with a sample size of 135 pharmacies. The Survey 
consists of four different segments, consisting mostly of tick box questions and two 
open questions. The lead researcher manually handed out and collected the surveys 
along with a participation letter. The data was analysed using Microsoft Excel. 
  
  
Ethics Statement 
Ethics committee approval was granted for this study. 
  
Results 
Low response rate (33.3%, n=45/135) was attained. Surprisingly, less than half of 
pharmacists (42.2%, n=19/45) had received dementia training. The majority of 
pharmacists that had received training had undertaken CPPE training (47.4%, 
n=9/19) and Dementia Friends (52.6%, n=10/19), with only a small fraction of 
pharmacists (26.3%, n=5/19) undertaking Dementia champions level of training. 
This is unfortunate, as the majority of pharmacists (80%, n=4/5) that have 
undertaken the programme found it “useful.” Over half of the pharmacists (64.4%, 
n=29) felt “confident to a certain extent” in advising carers regarding support of 
dementia patients and over two third of pharmacists (71.1%, n= 32) rated 
themselves as “mostly confident” to a certain extent at counselling dementia 
patients. Frailty was the most commonly (55.5%, n= 25) recognised co-morbidity of 
dementia, while only one pharmacist (2.2%, n=1) recognised seizures. Finally, a 
high number of pharmacists (77.7%, n= 35) claimed to be aware of the 
anticholinergic burden. However, this was untrue as antihistamines (cetirizine and 
chlorpromazine) were only recognised by just over one fifth of pharmacists (22.2%, 
n=10) as having an anti- cholinergic burden.             
        
Discussion             
This study has shown that, although it exists, dementia training needs to be further 
developed as pharmacists displayed a lack of knowledge about medication induced 
dementia and the co-morbidities associated with dementia. The most substantial 
limitation in this research is the poor response rate thus results cannot be 
generalised. Further work includes increasing the sample size. 
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